Hepatocellular carcinoma is the most common cancer in males. Surgery i
s the only curative treatment, but is applicable in only 10-15% of pat
ients. Systemic chemotherapy, transarterial embolization or chemo-embo
lization can only palliate. In the future, selective internal radiatio
n may have a role in downstaging inoperable hepatoma to operable tumou
r.